Update on Stroke Management
Abstract
Stroke affects nearly 800,000 people in the United States, and is a leading cause of disability and mortality. Increasing age is one of the most significant risk factors for stroke, and as our population continues to age, stroke is expected to become more prevalent. Strokes are categorized by either an ischemic event that impedes oxygen delivery to brain tissue, or by an intracranial hemorrhage. They present with similar symptoms, but must be correctly differentiated, as they are treated differently. Early diagnosis and treatment are key to successful patient prognosis. With an ischemic stroke, thrombolytics can reperfuse the affected tissue while it still remains viable. Likewise, early blood pressure management in a hemorrhagic stroke may decrease hematoma expansion and improve quality of life. Early management, along with secondary prevention of recurrent stroke and early physical therapy can safely lead to decreased neurological deficit and better functionality for patients.References
American Heart Association Writing Group. Heart Disease and Stroke Statistics—2013 Update. A Report from the American Heart Association Circulation. 2013;127:e6-e245
Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43-53.
Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55:1649 –1655.
Kalafut MA, Saver JL. The acute stroke patient: the first six hours. In: Cohen SN, editor.
Management of ischemic stroke. New York: McGraw-Hill; 2000. p. 17–52.
Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999;53:126–131.
Smith W, English J, Claiborne S. Claiborne Johnston. Cerebrovascular Diseases. In: Fauci AS, Braunwald E, Kasper DL, et al. eds. Harrison’s Principles of Internal Medicine, 17th edition, New York: McGraw Hill, 2008:2514.
Adams Jr. HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke : A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke. 2007;38:1655-1711.
Jamieson DG. Diagnosis of ischemic stroke. Am J Med. 2009;122:S14-S20.
Rymer MM, Armstrong EP, Walker G, et al. Analysis of a coordinated stroke center and regional stroke network on access to acute therapy and clinical outcomes. Stroke. 2013;44:132-137.
Barreto AD. Intravenous thrombolytics for ischemic stroke. Neurotherapeutics. 2011;8:388-399.
Lees Kr, Bluhmki E, von Kummer R, et al. ECASS, ATLANTIS, NINDS and EPITHET rtPA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS and EPITHET trials. Lancet. 2010;375:1695-1703.
Wardlaw JM, Murray V, Berge E, et al. Thrombolysis for acute ischemic stroke. Cochrane Database Syst Rev. 2009;(4):CD000213.
Jauch EC, Saver JL, Adams Jr. HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
Sherry S, Bell WR, Duckhert FH, et al. Thrombolytic therapy in thrombosis: A National Institutes of Health Consensus Development Conference. Ann Intern Med. 1980;93:141-144.
Morgenstern LB, Hemphill III JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108-2129.
Ansell J, Hirsh J, Hylek E. Pharmacology and management of the vitamin K antagonists:
American College of Chest Physicians Evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133(6Suppl):160S-198S.
Fredriksson K, Norrving B, Strömblad LB. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke. 1992;23:972-977.
Jauch EC, Lindsell CJ, Adeoye O, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061-2065.
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38:637-648.
Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage trial (INTERACT2) N Engl J Med. 2013. DOI:10.1056/NEJMoa1214609.
Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397.
Sandercock PAG, Counsell C, Gubitz GJ, et al. Antiplatelet therapy for acute ischemic stroke [update of Cochrane Database Syst Rev. 2003;CD000029;PMID: 12804384]. Cochrane Database Syst Rev.2008;CD000029.
The International Stroke Trial (IST).A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349:1569–81.
CAPRIE Steering committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-39.
Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-7.
Verro P, Gorelick PB, Nguyen D. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis. Stroke. 2008;39:1358-1363.
Sacco RL, Diener H-C, Yusuf S, et al for the PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008; 359:1238-1251.
Shinohara Y, Katayama Y, Uchiyama S, et al. CSPS-2 group. Cilostazol for prevention of secondary stroke (CSPS-2): an aspirin-controlled, double-blind, randomized non-inferiority trial. Lancet Neurol. 2010;9:959-68.
Lansberg MG, O’Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based practice guidelines. Chest. 2012;141(Suppl):e601S-36S.
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-67.
You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-based practice guidelines. Chest. 2012;141(Suppl):e531S-75S.
de Bruijn SFTM, Agema WRP, Lammers GJ, et al. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke. 2006;37:2531-2534.
O’Regan C, Wu P, Arora P, et al. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am Journal of Medicine. 2008;121:24-33.
Collins R, Armitage J, Parish S, et al. for the Heart Protection Study Collaborative Study Group. Effects of cholesterol lowering with simvastatin on stroke and other major cardiovascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757-67.
Amarenco P, Bogousslavsky J, Callahan A III, et al. for the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-59.
Sui X. A prospective study of fasting plasma glucose and risk of stroke in asymptomatic men. Mayo Clin Proc. 2011;86:1042-9.
Johnston KC, Hall CE, Kissela BM, et al. Glucose regulation in acute stroke patients (GRASP) trial: a randomized pilot trial. Stroke. 2009;40:3804-3809.
Bellolio MF, Gilmore RM, Stead LG. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev. 2011;(9).
Duncan PW, Zorowitz R, Bates B, et al. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke. 2005;36(9):e100-43.
Knecht S, Hesse S, Oster, P. Rehabilitation after stroke. Dtsch Arztebl Int. 2011;108:600-6.
Cumming TB, Thrift AG, Collier JM, et al. Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke. 2011;42:153-8.
Ebell MH, Siwek J, Weiss BD, et al. Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004;69:548-56.
Downloads
Published
How to Cite
Issue
Section
License
Accepted 2014-01-16
Published 2014-01-01
